These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 14515211)

  • 1. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene analysis of Epstein-Barr virus-associated lymphomas in Hu-Pbl/SCID chimeras.
    Gan R; Xie X; He J; Liu X; Hong L; Tang Y; Liu F; Xie H
    Tumori; 2010; 96(3):465-72. PubMed ID: 20845810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
    Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
    J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
    Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
    Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation.
    Lau SK; Chen YY; Berry GJ; Yousem SA; Weiss LM
    Mod Pathol; 2003 Dec; 16(12):1242-7. PubMed ID: 14681325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients.
    Camilleri-Broët S; Camparo P; Mokhtari K; Hoang-Xuan KH; Martin A; Arborio M; Hauw JJ; Raphaël M
    Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
    Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
    Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
    Komano J; Takada K
    J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.
    Tang Y; He R; Zhang Y; Liu F; Cheng A; Wu Y; Gan R
    Virol J; 2011 May; 8():213. PubMed ID: 21554672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
    Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.